ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The effects of dexmedetomidine for patient-controlled analgesia on postoperative sleep quality and gastrointestinal motility function after surgery: A prospective, randomized, double-blind, and controlled trial

Sui, Xin; Wang, Yue; Jin, Mingxin; Li, Kun; Jiang, Ge; Song, Ailing; He, Zhaoyi; Yin, Chengke; Zhao, Jingshun; Wang, Liping; Han, Fei*哈尔滨医科大学; 同济大学; 中国医学科学院
Frontiers in Pharmacology2022-10-10DOI: 10.3389/fphar.2022.990358
1被引7阅读
引用收藏
分享

摘要

Background: Postoperative poor sleep quality and decreased gastrointestinal motility function are common clinical problems. This study investigated the effects of dexmedetomidine (DEX) combined with sufentanil for patient-controlled analgesia (PCA) on postoperative sleep quality and gastrointestinal motility function after surgery in patients with colorectal cancer.Methods: Patients undergoing colorectal cancer surgery were randomly divided into three groups, DEX 0, 200, or 400 mu g, each combined with sufentanil 150 mu g for PCA immediately after surgery. The primary outcome was sleep quality in the first 7 days after surgery based on the Athens Insomnia Scale (AIS) score. The secondary outcome was postoperative gastrointestinal motility recovery evaluated by the time of first flatus, first feces and first diet. Postoperative pain intensity, side effects and the length of postoperative hospital stay were also compared among groups. The study was registered with the Chinese Clinical Trial Registry (, ChiCTR2000032601).Results: Ultimately, 210 cases were included. Sleep quality was better in the DEX 200 mu g group and DEX 400 mu g group than in the DEX 0 mu g group. Overall, in the DEX 200 mu g group and DEX 400 mu g group, the AIS score (p < 0.05) and the incidence of sleep disturbance (7.3%, 4.5% vs. 19.6%, p < 0.001) were lower than those in the DEX 0 mu g group in the first 7 days after surgery. There were no significant differences in postoperative gastrointestinal motility among the three groups in the total surgical categories (p > 0.05). In the laparoscopic surgery patients of each group, the time of postoperative first flatus (p = 0.02) and first feces (p = 0.01) was significantly longer in the DEX 400 mu g group than in the DEX 0 mu g group. There were no differences in postoperative pain intensity, side effects or length of postoperative hospital stay (p > 0.05).Conclusion: The continuous infusion of DEX (200 or 400 mu g) for PCA significantly improved postoperative sleep quality after colorectal cancer surgery. DEX (200 mu g) was better at improving postoperative sleep quality without affecting gastrointestinal motility function than DEX (400 mu g) in patients who underwent laparoscopic colorectal cancer surgery.

学科与关键词

关键词
dexmedetomidinepatient-controlled analgesiapostoperative sleep qualitypostoperative gastrointestinal motility functioncolorectal cancer surgery
相关
加载中…
  • Effect of Perioperative Dexmedetomidine Anesthesia on Prognosis of Elderly Patients with Gastrointestinal Tumor Surgery
    Guo, Lijia; Liu, Yufei*; Wang, MeitanComputational and Mathematical Methods in Medicine, 2022, 2022: 7889372.被引 2
  • Effects of Dexmedetomidine on Systemic Inflammation and Postoperative Complications in Laparoscopic Pancreaticoduodenectomy: A Double-blind Randomized Controlled Trial
    Chen, Yan-Xin; Du, Lin; Wang, Li-Nan; Shi, Yong-Yong; Liao, Min; Zhong, Min*; Zhao, Gao-Feng*World Journal of Surgery, 2023, 47(2): 500-509.
  • Effects of Dexmedetomidine on Patients Undergoing Laparoscopic Surgery for Colorectal Cancer
    Sun, Wenqin; Li, Fengling; Wang, Xianxue; Liu, Hongbo; Mo, Hong; Pan, Daobo; Wen, Shihong*; Zhou, Aiguo*Journal of Surgical Research, 2021, 267: 687-694.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-10-10
卷期
第 13 卷
页码
990358
DOI
10.3389/fphar.2022.990358
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [81871515]; [82171859]

作者

  • S

    Sui, Xin (第一作者)

    harbin med univ

  • W

    Wang, Yue

    tongji univ

查看全部 11 位作者收起作者
  • J

    Jin, Mingxin

    chinese acad med sci

  • L

    Li, Kun

    harbin med univ

  • J

    Jiang, Ge

    harbin med univ

  • S

    Song, Ailing

    harbin med univ

  • H

    He, Zhaoyi

    harbin med univ

  • Y

    Yin, Chengke

    harbin med univ

  • Z

    Zhao, Jingshun

    harbin med univ

  • W

    Wang, Liping

    harbin med univ

  • H

    Han, Fei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417